James Brumley

GHI-Plexi Images / UCG / Universal Images Group via Getty Images Marsh McLennan reported second-quarter earnings and sales below Wall Street's estimates.

There's no decisive reason the stock should be up this week. The headlines have been leaning in a bearish direction, in fact.

Key Points Kraft Heinz has underperformed for so long that many investors forgot about it. That's the time to dust it off and take a fresh look. Insurance outfit Chubb isn't an exciting investment, but what it lacks in pizzazz it makes up for in reliability. Kroger's plans to acquire rival grocer Albertsons are hitting the expected snags, but they won't stop the merger.

Key Points Dutch Bros shares are up 70% from the all-time low they touched in October. The stock's big gains reflect the underlying company's growth. The coffee drive-thru chain has ambitious expansion plans. Motley Fool Issues Rare “All In” Buy Alert

At first glance, Roku (NASDAQ: ROKU) looks like a stock to avoid. Shares are trading down 87% from their 2021 peak, for instance, and still within sight of their early 2023 low.

Key Points Most people in their late 40s and early 50s don't exactly have robust retirement savings yet. Your specific number right now isn't nearly as important as your plan and process for growing it. Motley Fool Issues Rare “All In” Buy Alert

Key Points Most made sure they received any money their employer was willing to give to the effort. These millionaire investors also played the odds of achieving their highest potential growth. Time remains an investor's biggest ally when it comes to achieving strong returns. Motley Fool Issues Rare “All In” Buy Alert

The market seems to be underestimating this up-and-coming company's potential growth.

No single stock you own is likely to meaningfully help you become a millionaire, but there are some rare exceptions.

Key Points The drugmaker's newest therapies are seeing unexpectedly strong sales growth. Its legacy drug portfolio, meanwhile, is still a solid cash cow. Even with today's big boost, Bristol Myers Squibb shares are still trading at an unnecessary discount. Motley Fool Issues Rare “All In” Buy Alert